An upregulation of UCP2 has already been reported for several cancer types, including breast invasive cancer, thyroid carcinoma, lung carcinoma, bladder urothelial cancer, and colorectal adenocarcinoma (Madreiter-Sokolowski et al., 2017b). This evidence concerns the gene UCP2 and thyroid gland carcinoma.